Skip to main content
. 2015 May 20;10(5):e0114586. doi: 10.1371/journal.pone.0114586

Fig 8. MEG3 expression levels are positively correlated with the responses of patients to cisplatin-based chemotherapy.

Fig 8

(Fig 8A) qRT-PCR analysis of MEG3 expression levels in cisplatin-sensitive (n = 20) and cisplatin-insensitive (n = 21) LAD tissues. (Fig 8B) Kaplan–Meier survival analysis of the association between PFS of LAD patients and MEG3 expression (log rank P < 0.001). (Fig 8C) Cisplatin-sensitive tissues exhibited higher p53 and lower Bcl-xl protein expression than cisplatin-insensitive tissues. Original magnification, ×200 or ×400. ** P < 0.01.